Terms and Agreement
Please agree to the terms to continue using the chat feature.
Based in Ann Arbor, Michigan, Zomedica is a veterinary health company creating diagnostic and therapeutic products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. With modest cash burn and a strong balance sheet, including $91 million cash, cash equivalents, and available-for-sale securities as of March 31, 2024, Zomedica is well-positioned to fund both organic growth and acquisitions. The Company’s portfolio includes innovative products that emphasize both patient and practice health, including:
Diagnostics and Therapeutic Devices:
Therapeutic Devices:
Zomedica’s mission is to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care.
Zomedica’s rapidly increasing revenues and attractive gross margins offer a clear pathway to profitability. Successful acquisitions and collaborations provide a blueprint for continued organic growth and product expansion. With a product line-up designed to address the needs of both companion animals and the veterinarians they rely upon and an animal health market that continues to exponentially grow, Zomedica finds itself primed to capitalize on a substantial amount of market opportunities. Having accelerated its commercial launch cadence, Zomedica continues to address the unmet needs of the customers and the market it serves. With double-digit revenue growth and strong margins, combined with a decreasing operating cash burn, a strong balance sheet (incl. $91 million in liquidity with no debt), and profitability on the horizon, Zomedica is well positioned as a very compelling opportunity for fast-acting investors.
Red Chat is here to summarize the SEC filing data on ZOM
Please agree to the terms to continue using the chat feature.